If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for more risk picks up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The blue-chip FTSE 100 and mid-cap FTSE 250 are both up year to date. Here, I’ll look at what I’d have now if I’d invested £25k in the FTSE 350 index at the beginning of January.

What is it?

The index in question combines the largest 350 companies listed on the London Stock Exchange, specifically the constituents of the FTSE 100 and FTSE 250.

It offers a broad view of UK corporate performance, spanning diverse sectors like finance, healthcare, energy, and consumer goods. As such, it can be seen as a benchmark for the overall economic health of the UK.

Should you invest £1,000 in Vodafone right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Vodafone made the list?

See the 6 stocks

How much?

Unfortunately, the UK economy hasn’t exactly been firing on all cylinders in recent times. Perhaps this is why the FTSE 350 has returned just 30.7% in the past five years, including dividends.

Things have picked up a bit lately though. As of 30 September, the year-to-date total return was approximately 10%. This means that I’d have around £27,500 in my account if I’d invested £25,000 in a tracker like the iShares 350 UK Equity Index Fund.

With inflation falling and more interest rate cuts on the horizon, consumers should have more money to spend. Therefore, I wouldn’t be surprised to see the index inch higher in the coming months.

Buying individual shares

I often look at the S&P 500 — up 200% in 10 years with dividends — and wonder if I should just buy a US tracker, an exchange-traded fund (ETF). It would save me a lot of time researching and following individual shares.

Then again, I’d totally miss out on stocks that can go up 10, 20, or even 50 times in value over time. Personally, I’d rather take on more risk for greater potential reward, at least at this stage.

However, when it comes to FTSE trackers, the meagre historical returns have never tempted me to invest. Instead, I’d rather buy individual UK shares that I think can beat the market.

A true FTSE heavyweight

One stock that I think can carry on outperforming is the FTSE 350’s largest constituent: AstraZeneca (LSE: AZN). Shares of the global pharma giant have returned an annualised 10.2% over the past five years, easily beating the FTSE 100’s 6.1%.

Created with Highcharts 11.4.3AstraZeneca Plc PriceZoom1M3M6MYTD1Y5Y10YALL4 Nov 20194 Nov 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

In the first half of 2024, the company’s revenue increased 18% year on year to $25.6bn, driven by double-digit growth across all four divisions. Oncology, its largest unit, grew by an impressive 22%.

One risk I do see here is the new US law requiring drugmakers to negotiate prices with the government’s Medicare health insurance programme (covering 66m people). This could impact future earnings.

Still, I think the stock is set up for further gains. AstraZeneca’s pipeline is massive and it’s aiming to launch 20 new medicines by 2030. It’s targeting $80bn in annual revenue by then, up from $45.8bn in 2023.

Plus, I think accelerating advances in artificial intelligence (AI) could revolutionise the industry. The firm is already “embracing the adoption of responsible AI solutions, from discovery to clinical trials, treatment delivery and beyond to bring the right medicines to the right patients, faster than ever before.”

Finally, AstraZeneca’s forward price-to-earnings multiple of 15.3 looks reasonable to me. I’d buy the stock to hold long term if I didn’t already own it.

Should you invest £1,000 in Vodafone right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Vodafone made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our best passive income stock ideas

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Investing Articles

Hunting for passive income? These falling insurance giants offer 10% yields

The UK insurance sector is typically a good place to look for attractive dividend yields. Dr James Fox details two…

Read more »

Investing Articles

Considering a Stocks and Shares ISA this April? Avoid these mistakes!

When opening a Stocks and Shares ISA for the first time, it's easy to fall foul of some costly mistakes.…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

With global markets down 10%+ investors should remember this legendary quote from Warren Buffett

Warren Buffett is the greatest investor of all time. And he says that the best time to buy shares is…

Read more »

Investing Articles

I asked ChatGPT for the best safe havens in the FTSE 100 amid Trump’s tariffs 

Our writer isn't convinced by the answers that AI assistant ChatGPT rattled off when asked about solid FTSE 100 defensive…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 world-class shares to consider buying in the market sell-off

Looking for blue-chip shares to buy amid the market chaos? Here are two high-quality businesses that Edward Sheldon sees potential…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Consider targeting £8,840 of annual passive income from 363 shares in this FTSE 100 heavyweight stock!

Investing in high-dividend-paying stocks with the returns used to buy more of the shares can generate potentially life-changing passive income…

Read more »

Investing Articles

16% lower in 10 days, does Prudential’s share price look a compelling bargain to me?

Prudential’s share price is down a lot from its one-year traded high, which suggests a bargain to be had. I…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Down 17% in a week! This FTSE 100 growth stock is one I’m watching

Over the last five years, Informa has shown itself to be one of the UK’s most resilient growth stocks. So…

Read more »